chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I did not notice any major issues during the waiting period after receiving the shot, and conducted another errand afterwards.  While in that building, about an hour and a half after the vaccination, sudden sharp abdominal pain (nearly identical to the few occasions when I have eaten food that was inadvertently contaminated with shellfish or when I have been injected with iodine contrast by negligent technicians) hit me and I rushed to the bathroom.  Pain continued during and after, with moderate diarrhea and foul-odor gas occurring for the remainder of the day.  Extreme fatigue began about 1 pm, and continued for three days (near constant somnolence until Wednesday evening Dec 8th, with one- to two-hour interruptions when I forced myself to remain awake for meals, etc.)  Abdominal pain lessened by 9 pm December 6th, but loss of appetite and nausea continued through 1 pm December 7th.  Realized on December 9th (with abatement of symptom) that my tongue had been partially numb (mild, only on tip) for 3 days.
318PM c/o dizziness & flushed feeling in face; stated feel like my face is burning up; BP 320PM 128/84, P80; 337PM 118/72;
Itchy baseball size knot with redness in and around it.  Hot to the touch and swollen.
I had the booster the other day and it basically knocked me out.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "unknown", described as "I had the booster the other day and it basically knocked me out.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient received vaccine at 08:47 am and about 10 minutes later at around 9am , patient described having a tingling sensation radiating from her from shoulder to her hand.  patient hand appeared a little swollen, patient was advised to remain in the post vaccination site for further evaluation and  given 15 ml of Benadryl and a bottle of water . Patient was monitored  approximately every 15 minutes till about 10:15am , patient described still having  tingling sensation , but patient felt well enough  and headed home. Was advised to seek further medical attention if she continued to have symptoms from the vaccine.
pt recv vax 4JAN96 & pt exposed to varicella @ daycare 7OCT96 on 14OCT96 pt devel outbreak of less than 50 vesicular lesions; & rhinorrhea;
24 hours after vaccine. Her left upper Arm And elbow Area had redness, swelling and pain that extended to her upper forearm after 2days. Then the pain and swelling began to subside by day number 3 Also had Fever for 24-48 hours.
pt recv vax 26SEP90 & p/vax became very tired, nausea, diarrhea;felt weak & exhausted for several wk;AUG94 1st sx MS w/test that confirmed it APR95;pt not sure it this is connected to vax;
bronchiactasis flared up.; flare up; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of bronchial disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included bronchial disorder (had bronchiactasis).   On an unknown date, the patient received Shingles vaccine. On an unknown date, several days after receiving Shingles vaccine, the patient experienced bronchial disorder, condition aggravated and shingles. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the bronchial disorder, condition aggravated and shingles were unknown.   It was unknown if the reporter considered the bronchial disorder, condition aggravated and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient received shingles vaccine and few days later bronchiactasis flared up. The patient after suffering through 3 weeks of bronchiactasis nowhad full blown shingles. The patient received steroids for the breathing issues which caused a reaction to the shingles shot.
Kinrix given to a 7 years old patient; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa-IPV (Kinrix) (batch number JP55J5, expiry date 13th September 2022) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 26th July 2021, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 26th July 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The 7 years old patient received Kinrix, which led to inappropriate age at vaccine administration. The reporter wanted to know if this dose was valid or if needs to re done it. The reporter consented to follow up. This case was linked with case US2021160427, reported by same reporter for different patient. .; Sender's Comments:  US-GLAXOSMITHKLINE-US2021160427:Same reporter.
Orders were given to give patient Pediarix, PCV13, and Flu. Mom was aware I was going to give these vaccines. She agreed to have 2 vaccines in one thigh and one in the other thigh. First vaccine given Pediarix and patient started to cry and then given the Flu vaccine and patient wanted to cry but no sound came out and patient became bright red. Mom stated there is something wrong. The patient was not making a sound. Mom began to panic. Nurse writing grabbed the baby made sure there was a pulse and began a sternal rub. The patients color returned to normal until patient gasped and responded. Pt's vital signs remained stable and her exam was normal after episode. Patients mother elected to bring patient to emergency dept. for further evaluation.
Information has been received from an educator concerning a 7th to 9th grade female student, who "within the last 12 months" was vaccinated intramuscularly with a 0.5 mL dose of GARDASIL. The patient may have been vaccinated in combination with other vaccines that was needed to go back into middle school. "Within the last 12 months", when she got vaccinated, the patient felt "excruciating" pain. Subsequently, the patient had recovered at the time of vaccination. The reporter did not know if the patient experienced the adverse event with their 1st, 2nd or 3rd dose. The patient sought unspecified medical attention. This is one of several cases from the same source. Additional information has been requested.
Pt had swelling, size of grapefruit at injection site, pain dizziness and confusion. Hard lump at site. Pt went to ER MD sent pt him with no treatment just instructions to ice area. Pt went to primary MD-who prescribed BACTRIM DS 4/13/15 for cellulitis.
Became ill within 24-30 hrs post/vax w/nausea & vomiting & diarrhea. Seen by MD, 48 hrs post/vax, w/less irritability. R/anterior thigh injection site w/pea-sized nodule, non-tender; still has diarrhea, n/v but less. Temp 99.2.
I had diarrhea that had been ongoing for 4 days and I called my physician for an appointment.  Couldn't eat a thing and keep it in my body for more than a couple of hours.
Elbow swollen 3x normal size within a 10 minute period. Hot and painful to the touch. Red rash reaction between half of bicep and halfway down forearm
shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix. The reporter consented to follow up.
Increase swelling & erythema of entire thigh > 72 hrs Discomfort & ambulation > 48 hrs.
Covid 19 - verified by home testing - patient is fully recovered.  Paxvolid was prescribed (5 days)
Given IM injection of Pneumo-23 in left deltoid. Developed immediate pain and swelling that radiated to trapezius and clavicle over next 24 hours. Required IV antibiotics. Per review of hospital d/c summary, diagnosis of cellulitis is confirmed.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12(US) hours post puncture), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (NO adverse event) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053b22a) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12(US) hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (NO adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12(US) hours post puncture), PRODUCT STORAGE ERROR (Product storage error) and NO ADVERSE EVENT (NO adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (NO adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered more than 12(US) hours post puncture) and PRODUCT STORAGE ERROR (Product storage error). Concomitant medication details were not reported by the reporter. It was reported that patient received second booster dose. It was reported that the vial was initially stored in refrigerator on 04-Aug-2022. On 23-AUG-2022 at 9:40 AM, vial was first punctured. The vial was stored at room temperature post puncture for 25 hours and did not undergo any temperature excursion. Treatment details was not reported by the reporter. This case was linked to MOD-2022-633802 (E2B Linked Report). Sender's Comments: MOD-2022-633802: Other patient case.
Information has been received from a nurse concerning a female (age not reported) who on an unspecified date was vaccinated with a dose of GARDASIL. Subsequently the patient developed Guillian-Barre syndrome. At the time of this report, the outcome was unknown. Upon internal review, Guillian-Barre syndrome was considered an other important medical event. Additional information has been requested.
Client reported light-headedness immediately after 1st dose, which resolved within 15 minutes. Client reported hives developed approximately 10 hours after 1st dose bilaterally on lower arms. Hives resolved after a few days using unidentified itch cream.
Vaccination rec'd Thursday AM 7/19/12 and began with fever late Thursday afternoon until Saturday 7/21/12 night. Left upper arm red, hot, swollen. Today 7/23/12 pt. seen in office upon her calling to report s/s, arm less red, and swollen per pt. States feels itchy/prickly in (L) arm (upper) Rx BENADRYL & cold compress.
Fever 99.5 - 102.7 Nausea Dizziness/Vertigo Tiredness (slept most of the day) slight sore throat  joint pain, especially neck, back and wrists injection site swollen, hot  injection site/arm sore for 3 days
Patient received second dose of her Shingles series and she stated that she had a very sore arm, starting 12 hours after vaccine, as well as vomiting and diarrhea. Patient stated she had a sore arm 2 days after, and asked we report incident. Pt stated she did not feel the above after her first Shingles vaccine. Shingles vaccine in the suggested 2-6 month interval.
8 days after injection left arm turned red around the site of injection and began to grow and get worse, 9 days after it became hot, itchy, and the arm got firm in the spot where it was red. Took Benadryl thinking it was an allergic reaction and it did not do anything, continued to grow.
Information has been received from a physician concerning a patient's daughter (age unspecified) who was vaccinated with GARDASIL (date, dose unspecified). Subsequently the patient experienced seizure one month after dose one. In follow up, a phone call was received from an RN from the Dr's office. The RN reported that the physician did not have any additional information concerning the patient. Upon internal review, seizure was determined to be an other medical event. Additional information has been requested.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the patient was vaccinated with improperly stored ROTATEQ (strength, dose, frequency and route were not reported) lot # L008574 with an expiry of 22-NOV-2016. No concomitant medications were reported. No adverse effects were reported. This healthcare worker also inquired about the stability of M-M-R II, however, M-M-R II did not undergo a temperature excursion and is not included in this adverse event (AE). There was no product quality complaint involved. This is one of the several reports received from same reporter. Additional information has been requested.
PNEUMOVAX given 1AM 10/19/10. Patient came in 4:45PM 10/20/10 with sore arm, inflamed/red at site of injection stated fever night before (after shot) relieved by MOTRIN. Pt stated felt fine later that night went to Urgent Care received prescription for Prednisone 20mg 2 daily x 5 d.
Patient received Pfizer vaccine. 5 minutes later, patient started convulsing, experiencing syncope like reactions. He was cold, pale, heart beat was ~ 10-15 bpm. The patient was laid on the floor on his side as he was shaking for approximately 10 seconds. After a few minutes, regained consciousness and remembered details about his name, location, time, etc. Paramedics came and took patient to the hospital.
pt recv vax & exp a large induration on rt arm @ inj site (6cm x 4.5cm & redness & swelling @ the inj site;pt exp a vesicular rash on arms;visit to MD was required;
initially seen c/o of numbness tingling in lips approx 15-120mins p/vax; t99.6, RR16, HR80, BP 110/60;  progressed to slurred speech, lightheadness; No SOB given Epi;
This spontaneous report was received from a healthcare worker regarding a female patient of unknown age. On 20-JAN-2009 the patient was vaccinated with the first dose of VARIVAX (Merck) (dose, route, lot# not provided). On 18-JUL-2013, the patient was subsequently administered an expired dose of VARIVAX (Merck) (dose and route not provided) (Lot# reported as 1066AA, expiration date 05-JUL-2013) for the second dose in the vaccine series. No adverse effect was reported. Additional information has been requested.
Pain started at injection site on left deltoid and travels down her arm and sometimes to chest and top of back. Pain present daily but is intermittent.
Patient presented to the ED for atrial fibrillation on 4/9/21 and 4/20/21. Patient was hospitalized for atrial fibrillation .
Got the flu in December (strand B). Never fully recovered; low grade fevers throughout month of December and first week of January. Experienced severe dizziness as of January 5. Vertigo was ruled out along with any other neurological diseases of the brain. Speech is slurred and dizziness is still present. Can't walk independently; required assistance for most ADL's.
Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Dermatofibroma at site (subcutaneous tissue on left arm) of Pneumovax injection.  I first noticed a scab had formed on the site and was surprised.  It has never disappeared and now is an obvious (to me) dermatofibroma.  One on my right leg I believe was associated with an insect bite.  No problem, just thought injection might be associated with dermatofibroma at injection site.
Pt. reported having severe pain below left shoulder blade, shortness of breath, sweating, nausea, dizziness. Didn't feel bad at first but gradually getting worse. Told pt. to call Dr. They advised this was due to vaccination but weren't too worried about it. This was at 1530 hrs. Later, 1630hrs pt said he was feeling a little better - took BP, results below.
Pt experienced extreme edema & was hospitalized following adm. of Td vaccine. Condition was described as cellulitis of the lt arm. the pt fully recovered /p treatment /w antibiotics.
12 hours following the injection, I had high fevers and shaking chills for 48 hours, followed by prolonged nausea, abdominal pain, myalgias, anorexia, chills and fevers for an additional 5 days.  roughly 2-3 weeks following this, i had an episodes of recurrent bloody diarrhea, abdominal pain, nausea, anorexia.  I was evaluated by gastroenterologist who confirmed liver tenderness, and enlargement (~14cm).
SWOLLEN TONGUE; STOMACH ACHE; CHILLS; NAUSEA; HEADACHE; FATIGUE AGGRAVATED; This spontaneous report received from a consumer concerned a 50 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced swollen tongue, stomach ache, chills, nausea, headache, and fatigue aggravated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen tongue, stomach ache, chills, nausea, headache, and fatigue aggravated. This report was non-serious.
I developed an itchy red rash on my upper chest area. I took a dose of Allegra to alleviate the symptoms. Two days later I developed an itchy swollen patch on my left upper cheek around my eye and again took a dose of Allegra. Today, 04/04/21, after running 8 miles I developed  raised itchy patches on my lower neck and upper chest once again, a raised, red bump on each cheek, as well as raised red itchy patches in three places on my left arm, including near the original vaccination site. Once again I have taken Allegra to alleviate the symptoms.
Information has been received regarding a case involved in litigation concerning a pt who may or may not have experienced an unspecified adverse event.
Pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported. No treatment information was provided.
Was fine initially, a few weeks later started to have more pain in my legs and back.  Had to take more pain meds. Started to get tired more and legs swelled more. Now, 8/12/21 I have extreme back pain that I have to be on pain killer every 5 hrs to be able to move. My knees have swelling and have  developed cysts on both knees now.  My arthritis in my hands are worse to where I have shooting pain. I have trouble sleeping, restless leg has increases.  Have had shortness of breath for past 3 mo.
FEVER; sweating; CHILLS; RASH; HEADACHE; Dizzy; Red rash all over neck and chest; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), RASH ERYTHEMATOUS (Red rash all over neck and chest), CHILLS (CHILLS), HEADACHE (HEADACHE) and PYREXIA (FEVER) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported).   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced DIZZINESS (Dizzy) and RASH ERYTHEMATOUS (Red rash all over neck and chest). On 01-Jan-2021, the patient experienced HEADACHE (HEADACHE). On 28-Jan-2021, the patient experienced RASH (RASH). On 29-Jan-2021, the patient experienced CHILLS (CHILLS). On an unknown date, the patient experienced PYREXIA (FEVER) and HYPERHIDROSIS ( sweating ). At the time of the report, DIZZINESS (Dizzy), CHILLS (CHILLS), HEADACHE (HEADACHE) and HYPERHIDROSIS ( sweating ) had not resolved and RASH ERYTHEMATOUS (Red rash all over neck and chest), PYREXIA (FEVER) and RASH (RASH) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement (120/80-161/71 mmHg): 161/71 mmHg 161/71.
bruising; coughing; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (bruising) and COUGH (coughing) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONTUSION (bruising) and COUGH (coughing). At the time of the report, CONTUSION (bruising) and COUGH (coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided